Literature DB >> 21624904

Erythema migrans in Lyme disease.

David A Wetter1, Colin A Ruff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21624904      PMCID: PMC3153519          DOI: 10.1503/cmaj.101533

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.

Authors:  Robert P Smith; Robert T Schoen; Daniel W Rahn; Vijay K Sikand; John Nowakowski; Dennis L Parenti; Mary S Holman; David H Persing; Allen C Steere
Journal:  Ann Intern Med       Date:  2002-03-19       Impact factor: 25.391

2.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

3.  Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques.

Authors:  J Nowakowski; I Schwartz; D Liveris; G Wang; M E Aguero-Rosenfeld; G Girao; D McKenna; R B Nadelman; L F Cavaliere; G P Wormser
Journal:  Clin Infect Dis       Date:  2001-11-07       Impact factor: 9.079

  3 in total
  1 in total

1.  Bull's-Eye and Nontarget Skin Lesions of Lyme Disease: An Internet Survey of Identification of Erythema Migrans.

Authors:  John N Aucott; Lauren A Crowder; Victoria Yedlin; Kathleen B Kortte
Journal:  Dermatol Res Pract       Date:  2012-10-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.